BELITE BIO, INC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.29 USD | +0.58% |
|
+7.12% | -0.77% |
| 05-14 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.31B | - | - | - | - | - | |
| 62.59B | - | |||||
| 41.18B | ||||||
| 40.29B | ||||||
| 27.9B | ||||||
| 26.21B |
- Stock Market
- Equities
- BLTE Stock
- Charts Belite Bio, Inc
- Sector Chart
